IJMS | Free Full-Text | Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
Primary thrombocytosis in children | Haematologica
Mutations and thrombosis in essential thrombocythemia | Blood Cancer Journal
European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms
Frontiers | Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
Diagnostic algorithm of Essential thrombocythemia (ET). | Download Scientific Diagram
Essential thrombocythemia treatment algorithm 2018 | Blood Cancer Journal
Cancers | Free Full-Text | Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects: Trends in Molecular Medicine
Clinical Targeted NGS Detection of Type 1 CALR Mutation in a case of Essential Thrombocythemia | Case Studies | News
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management - Tefferi - 2017 - American Journal of Hematology - Wiley Online Library
ESSENTIAL THROMBOCYTHEMIA (ET) – MPN Research Foundation
JAK2 Reflex for Essential Thrombocythemia
Essential Thrombocythemia | Oncohema Key
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice - Mayo Clinic Proceedings
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 | Leukemia
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management - Tefferi - 2020 - American Journal of Hematology - Wiley Online Library
JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review | Semantic Scholar
Pathophysiology of thrombosis in myeloproliferative neoplasms | Haematologica
A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text
Essential thrombocythemia | Orphanet Journal of Rare Diseases | Full Text
Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome | Haematologica
JAK2 and MPL Mutation Screening: What Are the Indications and How to Interpret the Results - The ASCO Post
Frontiers | Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
Essential Thrombocytosis (ET) | Myeloproliferative Neoplasm (JAK2 Kinase) - YouTube
Recent advances in understanding myelofibrosis... | F1000Research
